No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P-Glycoprotein

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1392
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Induction of Cytochrome P450 CYP3A by St John's Wort in the Rat Liver and Intestine

Integrative Medicine Insights
Alternative MedicineComplementary
2007English

St John's Wort (Hypericum Perforatum): Drug Interactions and Clinical Outcomes

British Journal of Clinical Pharmacology
Pharmacology
2002English

St John's Wort for Depression

BMJ
1996English

No Evidence for Interactions of Dimethylfumarate (DMF) and Its Main Metabolite Monomethylfumarate (MMF) With Human Cytochrome P450 (CYP) Enzymes and the P‐glycoprotein (P‐gp) Drug Transporter

Pharmacology Research and Perspectives
ToxicologyNeurologyPharmaceuticsPharmacology
2019English

Time-Dependent Induction of Midazolam-1-Hydroxylation Enzymes in Rats Treated With St. John's Wort

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2005English

Nutrition and Health Info Sheet: St. John's Wort

2008English

Reduction of Hyperbilirubinemia With Hypericum Extract (St. John's Wort) in a Patient With Crigler-Najjar Syndrome Type II

British Journal of Clinical Pharmacology
Pharmacology
2016English

St. John's Wort and Its Active Principles in Depression and Anxiety

British Journal of Clinical Pharmacology
Pharmacology
2006English

Inhibition of Tumour Cell Growth by Hyperforin, a Novel Anticancer Drug From St. John's Wort That Acts by Induction of Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy